The global Tuberculosis Diagnostics Testing market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.

Tuberculosis diagnostic testing is the process of detecting Mycobacterium tuberculosis infection and evaluating disease status through a range of methods, such as skin tests, sputum sample analysis, imaging and blood tests, and molecular biology techniques. These tests help to confirm the presence and type of TB.

The North American market for Tuberculosis Diagnostics Testing is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.

The Asia-Pacific market for Tuberculosis Diagnostics Testing is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.

The global market for Tuberculosis Diagnostics Testing in Medical Diagnosis is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 to 2032.

Major global companies of Tuberculosis Diagnostics Testing include Abbott Laboratories, Becton, Dickinson and Company (BD), BioMerieux SA, Cepheid (Danaher Corporation), Hologic, Inc., Hain Lifescience GmbH, Oxford Immunotec (PerkinElmer), Qiagen N.V., Roche Molecular Systems Inc., Siemens Healthineers AG, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.

This report delivers a comprehensive overview of the global Tuberculosis Diagnostics Testing market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Tuberculosis Diagnostics Testing. The Tuberculosis Diagnostics Testing market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global Tuberculosis Diagnostics Testing market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.

This report will assist Tuberculosis Diagnostics Testing manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Market Segmentation

Scope of Tuberculosis Diagnostics Testing Market Report

Report Metric	Details
Report Name	Tuberculosis Diagnostics Testing Market
Segment by Type	Diagnostic Laboratory Molecular Diagnostics Cytokine Detection Assay Others
Segment by Application	Medical Diagnosis Epidemiologic Investigations Public Health Control Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Abbott Laboratories, Becton, Dickinson and Company (BD), BioMerieux SA, Cepheid (Danaher Corporation), Hologic, Inc., Hain Lifescience GmbH, Oxford Immunotec (PerkinElmer), Qiagen N.V., Roche Molecular Systems Inc., Siemens Healthineers AG, Thermo Fisher Scientific Inc.
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Tuberculosis Diagnostics Testing companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.

FAQ for this report

Who are the main players in the Tuberculosis Diagnostics Testing Market report?

Ans: The main players in the Tuberculosis Diagnostics Testing Market are Abbott Laboratories, Becton, Dickinson and Company (BD), BioMerieux SA, Cepheid (Danaher Corporation), Hologic, Inc., Hain Lifescience GmbH, Oxford Immunotec (PerkinElmer), Qiagen N.V., Roche Molecular Systems Inc., Siemens Healthineers AG, Thermo Fisher Scientific Inc.

What are the Application segmentation covered in the Tuberculosis Diagnostics Testing Market report?

Ans: The Applications covered in the Tuberculosis Diagnostics Testing Market report are Medical Diagnosis, Epidemiologic Investigations, Public Health Control, Others

What are the Type segmentation covered in the Tuberculosis Diagnostics Testing Market report?

Ans: The Types covered in the Tuberculosis Diagnostics Testing Market report are Diagnostic Laboratory, Molecular Diagnostics, Cytokine Detection Assay, Others

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Tuberculosis Diagnostics Testing Market Size Growth Rate by Type: 2021 vs 2025 vs 2032

1.2.2 Diagnostic Laboratory

1.2.3 Molecular Diagnostics

1.2.4 Cytokine Detection Assay

1.2.5 Others

1.3 Market by Application

1.3.1 Global Tuberculosis Diagnostics Testing Market Growth by Application: 2021 vs 2025 vs 2032

1.3.2 Medical Diagnosis

1.3.3 Epidemiologic Investigations

1.3.4 Public Health Control

1.3.5 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Tuberculosis Diagnostics Testing Market Perspective (2021–2032)

2.2 Global Tuberculosis Diagnostics Testing Growth Trends by Region

2.2.1 Global Tuberculosis Diagnostics Testing Market Size by Region: 2021 vs 2025 vs 2032

2.2.2 Tuberculosis Diagnostics Testing Historic Market Size by Region (2021–2026)

2.2.3 Tuberculosis Diagnostics Testing Forecasted Market Size by Region (2027–2032)

2.3 Tuberculosis Diagnostics Testing Market Dynamics

2.3.1 Tuberculosis Diagnostics Testing Industry Trends

2.3.2 Tuberculosis Diagnostics Testing Market Drivers

2.3.3 Tuberculosis Diagnostics Testing Market Challenges

2.3.4 Tuberculosis Diagnostics Testing Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Tuberculosis Diagnostics Testing Players by Revenue

3.1.1 Global Top Tuberculosis Diagnostics Testing Players by Revenue (2021–2026)

3.1.2 Global Tuberculosis Diagnostics Testing Revenue Market Share by Players (2021–2026)

3.2 Global Top Tuberculosis Diagnostics Testing Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)

3.3 Global Key Players Ranking by Tuberculosis Diagnostics Testing Revenue

3.4 Global Tuberculosis Diagnostics Testing Market Concentration Ratio

3.4.1 Global Tuberculosis Diagnostics Testing Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Tuberculosis Diagnostics Testing Revenue in 2025

3.5 Global Key Players of Tuberculosis Diagnostics Testing Head Offices and Areas Served

3.6 Global Key Players of Tuberculosis Diagnostics Testing, Products and Applications

3.7 Global Key Players of Tuberculosis Diagnostics Testing, Date of General Availability (GA)

3.8 Mergers and Acquisitions, Expansion Plans

4 Tuberculosis Diagnostics Testing Breakdown Data by Type

4.1 Global Tuberculosis Diagnostics Testing Historic Market Size by Type (2021–2026)

4.2 Global Tuberculosis Diagnostics Testing Forecasted Market Size by Type (2027–2032)

5 Tuberculosis Diagnostics Testing Breakdown Data by Application

5.1 Global Tuberculosis Diagnostics Testing Historic Market Size by Application (2021–2026)

5.2 Global Tuberculosis Diagnostics Testing Forecasted Market Size by Application (2027–2032)

6 North America

6.1 North America Tuberculosis Diagnostics Testing Market Size (2021–2032)

6.2 North America Tuberculosis Diagnostics Testing Market Growth Rate by Country: 2021 vs 2025 vs 2032

6.3 North America Tuberculosis Diagnostics Testing Market Size by Country (2021–2026)

6.4 North America Tuberculosis Diagnostics Testing Market Size by Country (2027–2032)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Tuberculosis Diagnostics Testing Market Size (2021–2032)

7.2 Europe Tuberculosis Diagnostics Testing Market Growth Rate by Country: 2021 vs 2025 vs 2032

7.3 Europe Tuberculosis Diagnostics Testing Market Size by Country (2021–2026)

7.4 Europe Tuberculosis Diagnostics Testing Market Size by Country (2027–2032)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Ireland

8 Asia-Pacific

8.1 Asia-Pacific Tuberculosis Diagnostics Testing Market Size (2021–2032)

8.2 Asia-Pacific Tuberculosis Diagnostics Testing Market Growth Rate by Region: 2021 vs 2025 vs 2032

8.3 Asia-Pacific Tuberculosis Diagnostics Testing Market Size by Region (2021–2026)

8.4 Asia-Pacific Tuberculosis Diagnostics Testing Market Size by Region (2027–2032)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia & New Zealand

9 Latin America

9.1 Latin America Tuberculosis Diagnostics Testing Market Size (2021–2032)

9.2 Latin America Tuberculosis Diagnostics Testing Market Growth Rate by Country: 2021 vs 2025 vs 2032

9.3 Latin America Tuberculosis Diagnostics Testing Market Size by Country (2021–2026)

9.4 Latin America Tuberculosis Diagnostics Testing Market Size by Country (2027–2032)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Tuberculosis Diagnostics Testing Market Size (2021–2032)

10.2 Middle East & Africa Tuberculosis Diagnostics Testing Market Growth Rate by Country: 2021 vs 2025 vs 2032

10.3 Middle East & Africa Tuberculosis Diagnostics Testing Market Size by Country (2021–2026)

10.4 Middle East & Africa Tuberculosis Diagnostics Testing Market Size by Country (2027–2032)

10.5 Israel

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Abbott Laboratories

11.1.1 Abbott Laboratories Company Details

11.1.2 Abbott Laboratories Business Overview

11.1.3 Abbott Laboratories Tuberculosis Diagnostics Testing Introduction

11.1.4 Abbott Laboratories Revenue in Tuberculosis Diagnostics Testing Business (2021–2026)

11.1.5 Abbott Laboratories Recent Development

11.2 Becton, Dickinson and Company (BD)

11.2.1 Becton, Dickinson and Company (BD) Company Details

11.2.2 Becton, Dickinson and Company (BD) Business Overview

11.2.3 Becton, Dickinson and Company (BD) Tuberculosis Diagnostics Testing Introduction

11.2.4 Becton, Dickinson and Company (BD) Revenue in Tuberculosis Diagnostics Testing Business (2021–2026)

11.2.5 Becton, Dickinson and Company (BD) Recent Development

11.3 BioMerieux SA

11.3.1 BioMerieux SA Company Details

11.3.2 BioMerieux SA Business Overview

11.3.3 BioMerieux SA Tuberculosis Diagnostics Testing Introduction

11.3.4 BioMerieux SA Revenue in Tuberculosis Diagnostics Testing Business (2021–2026)

11.3.5 BioMerieux SA Recent Development

11.4 Cepheid (Danaher Corporation)

11.4.1 Cepheid (Danaher Corporation) Company Details

11.4.2 Cepheid (Danaher Corporation) Business Overview

11.4.3 Cepheid (Danaher Corporation) Tuberculosis Diagnostics Testing Introduction

11.4.4 Cepheid (Danaher Corporation) Revenue in Tuberculosis Diagnostics Testing Business (2021–2026)

11.4.5 Cepheid (Danaher Corporation) Recent Development

11.5 Hologic, Inc.

11.5.1 Hologic, Inc. Company Details

11.5.2 Hologic, Inc. Business Overview

11.5.3 Hologic, Inc. Tuberculosis Diagnostics Testing Introduction

11.5.4 Hologic, Inc. Revenue in Tuberculosis Diagnostics Testing Business (2021–2026)

11.5.5 Hologic, Inc. Recent Development

11.6 Hain Lifescience GmbH

11.6.1 Hain Lifescience GmbH Company Details

11.6.2 Hain Lifescience GmbH Business Overview

11.6.3 Hain Lifescience GmbH Tuberculosis Diagnostics Testing Introduction

11.6.4 Hain Lifescience GmbH Revenue in Tuberculosis Diagnostics Testing Business (2021–2026)

11.6.5 Hain Lifescience GmbH Recent Development

11.7 Oxford Immunotec (PerkinElmer)

11.7.1 Oxford Immunotec (PerkinElmer) Company Details

11.7.2 Oxford Immunotec (PerkinElmer) Business Overview

11.7.3 Oxford Immunotec (PerkinElmer) Tuberculosis Diagnostics Testing Introduction

11.7.4 Oxford Immunotec (PerkinElmer) Revenue in Tuberculosis Diagnostics Testing Business (2021–2026)

11.7.5 Oxford Immunotec (PerkinElmer) Recent Development

11.8 Qiagen N.V.

11.8.1 Qiagen N.V. Company Details

11.8.2 Qiagen N.V. Business Overview

11.8.3 Qiagen N.V. Tuberculosis Diagnostics Testing Introduction

11.8.4 Qiagen N.V. Revenue in Tuberculosis Diagnostics Testing Business (2021–2026)

11.8.5 Qiagen N.V. Recent Development

11.9 Roche Molecular Systems Inc.

11.9.1 Roche Molecular Systems Inc. Company Details

11.9.2 Roche Molecular Systems Inc. Business Overview

11.9.3 Roche Molecular Systems Inc. Tuberculosis Diagnostics Testing Introduction

11.9.4 Roche Molecular Systems Inc. Revenue in Tuberculosis Diagnostics Testing Business (2021–2026)

11.9.5 Roche Molecular Systems Inc. Recent Development

11.10 Siemens Healthineers AG

11.10.1 Siemens Healthineers AG Company Details

11.10.2 Siemens Healthineers AG Business Overview

11.10.3 Siemens Healthineers AG Tuberculosis Diagnostics Testing Introduction

11.10.4 Siemens Healthineers AG Revenue in Tuberculosis Diagnostics Testing Business (2021–2026)

11.10.5 Siemens Healthineers AG Recent Development

11.11 Thermo Fisher Scientific Inc.

11.11.1 Thermo Fisher Scientific Inc. Company Details

11.11.2 Thermo Fisher Scientific Inc. Business Overview

11.11.3 Thermo Fisher Scientific Inc. Tuberculosis Diagnostics Testing Introduction

11.11.4 Thermo Fisher Scientific Inc. Revenue in Tuberculosis Diagnostics Testing Business (2021–2026)

11.11.5 Thermo Fisher Scientific Inc. Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Abbott Laboratories

Becton Dickinson and Company (BD)

BioMerieux SA

Cepheid(Danaher Corporation)

Hologic Inc

Hain Lifescience GmbH

QIAGEN N V

Roche Molecular Systems Inc.

Siemens Healthineers AG

Thermo Fisher Scientific Inc

Oxford Immunotec (PerkinElmer)

List of Tables

Table 1. Global Tuberculosis Diagnostics Testing Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032

Table 2. Key Players of Diagnostic Laboratory

Table 3. Key Players of Molecular Diagnostics

Table 4. Key Players of Cytokine Detection Assay

Table 5. Key Players of Others

Table 6. Global Tuberculosis Diagnostics Testing Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032

Table 7. Global Tuberculosis Diagnostics Testing Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Table 8. Global Tuberculosis Diagnostics Testing Market Size by Region (US$ Million), 2021–2026

Table 9. Global Tuberculosis Diagnostics Testing Market Share by Region (2021–2026)

Table 10. Global Tuberculosis Diagnostics Testing Forecasted Market Size by Region (US$ Million), 2027–2032

Table 11. Global Tuberculosis Diagnostics Testing Market Share by Region (2027–2032)

Table 12. Tuberculosis Diagnostics Testing Market Trends

Table 13. Tuberculosis Diagnostics Testing Market Drivers

Table 14. Tuberculosis Diagnostics Testing Market Challenges

Table 15. Tuberculosis Diagnostics Testing Market Restraints

Table 16. Global Tuberculosis Diagnostics Testing Revenue by Players (US$ Million), 2021–2026

Table 17. Global Tuberculosis Diagnostics Testing Market Share by Players (2021–2026)

Table 18. Global Top Tuberculosis Diagnostics Testing Players by Tier (Tier 1, Tier 2, and Tier 3), based on Tuberculosis Diagnostics Testing Revenue, 2025

Table 19. Ranking of Global Top Tuberculosis Diagnostics Testing Companies by Revenue (US$ Million) in 2025

Table 20. Global 5 Largest Players Market Share by Tuberculosis Diagnostics Testing Revenue (CR5 and HHI), 2021–2026

Table 21. Global Key Players of Tuberculosis Diagnostics Testing, Headquarters and Area Served

Table 22. Global Key Players of Tuberculosis Diagnostics Testing, Products and Applications

Table 23. Global Key Players of Tuberculosis Diagnostics Testing, Date of General Availability (GA)

Table 24. Mergers and Acquisitions, Expansion Plans

Table 25. Global Tuberculosis Diagnostics Testing Market Size by Type (US$ Million), 2021–2026

Table 26. Global Tuberculosis Diagnostics Testing Revenue Market Share by Type (2021–2026)

Table 27. Global Tuberculosis Diagnostics Testing Forecasted Market Size by Type (US$ Million), 2027–2032

Table 28. Global Tuberculosis Diagnostics Testing Revenue Market Share by Type (2027–2032)

Table 29. Global Tuberculosis Diagnostics Testing Market Size by Application (US$ Million), 2021–2026

Table 30. Global Tuberculosis Diagnostics Testing Revenue Market Share by Application (2021–2026)

Table 31. Global Tuberculosis Diagnostics Testing Forecasted Market Size by Application (US$ Million), 2027–2032

Table 32. Global Tuberculosis Diagnostics Testing Revenue Market Share by Application (2027–2032)

Table 33. North America Tuberculosis Diagnostics Testing Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 34. North America Tuberculosis Diagnostics Testing Market Size by Country (US$ Million), 2021–2026

Table 35. North America Tuberculosis Diagnostics Testing Market Size by Country (US$ Million), 2027–2032

Table 36. Europe Tuberculosis Diagnostics Testing Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 37. Europe Tuberculosis Diagnostics Testing Market Size by Country (US$ Million), 2021–2026

Table 38. Europe Tuberculosis Diagnostics Testing Market Size by Country (US$ Million), 2027–2032

Table 39. Asia-Pacific Tuberculosis Diagnostics Testing Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032

Table 40. Asia-Pacific Tuberculosis Diagnostics Testing Market Size by Region (US$ Million), 2021–2026

Table 41. Asia-Pacific Tuberculosis Diagnostics Testing Market Size by Region (US$ Million), 2027–2032

Table 42. Latin America Tuberculosis Diagnostics Testing Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 43. Latin America Tuberculosis Diagnostics Testing Market Size by Country (US$ Million), 2021–2026

Table 44. Latin America Tuberculosis Diagnostics Testing Market Size by Country (US$ Million), 2027–2032

Table 45. Middle East & Africa Tuberculosis Diagnostics Testing Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 46. Middle East & Africa Tuberculosis Diagnostics Testing Market Size by Country (US$ Million), 2021–2026

Table 47. Middle East & Africa Tuberculosis Diagnostics Testing Market Size by Country (US$ Million), 2027–2032

Table 48. Abbott Laboratories Company Details

Table 49. Abbott Laboratories Business Overview

Table 50. Abbott Laboratories Tuberculosis Diagnostics Testing Product

Table 51. Abbott Laboratories Revenue in Tuberculosis Diagnostics Testing Business (US$ Million), 2021–2026

Table 52. Abbott Laboratories Recent Development

Table 53. Becton, Dickinson and Company (BD) Company Details

Table 54. Becton, Dickinson and Company (BD) Business Overview

Table 55. Becton, Dickinson and Company (BD) Tuberculosis Diagnostics Testing Product

Table 56. Becton, Dickinson and Company (BD) Revenue in Tuberculosis Diagnostics Testing Business (US$ Million), 2021–2026

Table 57. Becton, Dickinson and Company (BD) Recent Development

Table 58. BioMerieux SA Company Details

Table 59. BioMerieux SA Business Overview

Table 60. BioMerieux SA Tuberculosis Diagnostics Testing Product

Table 61. BioMerieux SA Revenue in Tuberculosis Diagnostics Testing Business (US$ Million), 2021–2026

Table 62. BioMerieux SA Recent Development

Table 63. Cepheid (Danaher Corporation) Company Details

Table 64. Cepheid (Danaher Corporation) Business Overview

Table 65. Cepheid (Danaher Corporation) Tuberculosis Diagnostics Testing Product

Table 66. Cepheid (Danaher Corporation) Revenue in Tuberculosis Diagnostics Testing Business (US$ Million), 2021–2026

Table 67. Cepheid (Danaher Corporation) Recent Development

Table 68. Hologic, Inc. Company Details

Table 69. Hologic, Inc. Business Overview

Table 70. Hologic, Inc. Tuberculosis Diagnostics Testing Product

Table 71. Hologic, Inc. Revenue in Tuberculosis Diagnostics Testing Business (US$ Million), 2021–2026

Table 72. Hologic, Inc. Recent Development

Table 73. Hain Lifescience GmbH Company Details

Table 74. Hain Lifescience GmbH Business Overview

Table 75. Hain Lifescience GmbH Tuberculosis Diagnostics Testing Product

Table 76. Hain Lifescience GmbH Revenue in Tuberculosis Diagnostics Testing Business (US$ Million), 2021–2026

Table 77. Hain Lifescience GmbH Recent Development

Table 78. Oxford Immunotec (PerkinElmer) Company Details

Table 79. Oxford Immunotec (PerkinElmer) Business Overview

Table 80. Oxford Immunotec (PerkinElmer) Tuberculosis Diagnostics Testing Product

Table 81. Oxford Immunotec (PerkinElmer) Revenue in Tuberculosis Diagnostics Testing Business (US$ Million), 2021–2026

Table 82. Oxford Immunotec (PerkinElmer) Recent Development

Table 83. Qiagen N.V. Company Details

Table 84. Qiagen N.V. Business Overview

Table 85. Qiagen N.V. Tuberculosis Diagnostics Testing Product

Table 86. Qiagen N.V. Revenue in Tuberculosis Diagnostics Testing Business (US$ Million), 2021–2026

Table 87. Qiagen N.V. Recent Development

Table 88. Roche Molecular Systems Inc. Company Details

Table 89. Roche Molecular Systems Inc. Business Overview

Table 90. Roche Molecular Systems Inc. Tuberculosis Diagnostics Testing Product

Table 91. Roche Molecular Systems Inc. Revenue in Tuberculosis Diagnostics Testing Business (US$ Million), 2021–2026

Table 92. Roche Molecular Systems Inc. Recent Development

Table 93. Siemens Healthineers AG Company Details

Table 94. Siemens Healthineers AG Business Overview

Table 95. Siemens Healthineers AG Tuberculosis Diagnostics Testing Product

Table 96. Siemens Healthineers AG Revenue in Tuberculosis Diagnostics Testing Business (US$ Million), 2021–2026

Table 97. Siemens Healthineers AG Recent Development

Table 98. Thermo Fisher Scientific Inc. Company Details

Table 99. Thermo Fisher Scientific Inc. Business Overview

Table 100. Thermo Fisher Scientific Inc. Tuberculosis Diagnostics Testing Product

Table 101. Thermo Fisher Scientific Inc. Revenue in Tuberculosis Diagnostics Testing Business (US$ Million), 2021–2026

Table 102. Thermo Fisher Scientific Inc. Recent Development

Table 103. Research Programs/Design for This Report

Table 104. Key Data Information from Secondary Sources

Table 105. Key Data Information from Primary Sources

Table 106. Authors List of This Report

List of Figures

Figure 1. Tuberculosis Diagnostics Testing Picture

Figure 2. Global Tuberculosis Diagnostics Testing Market Size Comparison by Type (US$ Million), 2021–2032

Figure 3. Global Tuberculosis Diagnostics Testing Market Share by Type: 2025 vs 2032

Figure 4. Diagnostic Laboratory Features

Figure 5. Molecular Diagnostics Features

Figure 6. Cytokine Detection Assay Features

Figure 7. Others Features

Figure 8. Global Tuberculosis Diagnostics Testing Market Size by Application (US$ Million), 2021–2032

Figure 9. Global Tuberculosis Diagnostics Testing Market Share by Application: 2025 vs 2032

Figure 10. Medical Diagnosis Case Studies

Figure 11. Epidemiologic Investigations Case Studies

Figure 12. Public Health Control Case Studies

Figure 13. Others Case Studies

Figure 14. Tuberculosis Diagnostics Testing Report Years Considered

Figure 15. Global Tuberculosis Diagnostics Testing Market Size (US$ Million), Year-over-Year: 2021–2032

Figure 16. Global Tuberculosis Diagnostics Testing Market Size, (US$ Million), 2021 vs 2025 vs 2032

Figure 17. Global Tuberculosis Diagnostics Testing Market Share by Region: 2025 vs 2032

Figure 18. Global Tuberculosis Diagnostics Testing Market Share by Players in 2025

Figure 19. Global Tuberculosis Diagnostics Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

Figure 20. The Top 10 and 5 Players Market Share by Tuberculosis Diagnostics Testing Revenue in 2025

Figure 21. North America Tuberculosis Diagnostics Testing Market Size YoY Growth (US$ Million), 2021–2032

Figure 22. North America Tuberculosis Diagnostics Testing Market Share by Country (2021–2032)

Figure 23. United States Tuberculosis Diagnostics Testing Market Size YoY Growth (US$ Million), 2021–2032

Figure 24. Canada Tuberculosis Diagnostics Testing Market Size YoY Growth (US$ Million), 2021–2032

Figure 25. Europe Tuberculosis Diagnostics Testing Market Size YoY Growth (US$ Million), 2021–2032

Figure 26. Europe Tuberculosis Diagnostics Testing Market Share by Country (2021–2032)

Figure 27. Germany Tuberculosis Diagnostics Testing Market Size YoY Growth (US$ Million), 2021–2032

Figure 28. France Tuberculosis Diagnostics Testing Market Size YoY Growth (US$ Million), 2021–2032

Figure 29. U.K. Tuberculosis Diagnostics Testing Market Size YoY Growth (US$ Million), 2021–2032

Figure 30. Italy Tuberculosis Diagnostics Testing Market Size YoY Growth (US$ Million), 2021–2032

Figure 31. Russia Tuberculosis Diagnostics Testing Market Size YoY Growth (US$ Million), 2021–2032

Figure 32. Ireland Tuberculosis Diagnostics Testing Market Size YoY Growth (US$ Million), 2021–2032

Figure 33. Asia-Pacific Tuberculosis Diagnostics Testing Market Size YoY Growth (US$ Million), 2021–2032

Figure 34. Asia-Pacific Tuberculosis Diagnostics Testing Market Share by Region (2021–2032)

Figure 35. China Tuberculosis Diagnostics Testing Market Size YoY Growth (US$ Million), 2021–2032

Figure 36. Japan Tuberculosis Diagnostics Testing Market Size YoY Growth (US$ Million), 2021–2032

Figure 37. South Korea Tuberculosis Diagnostics Testing Market Size YoY Growth (US$ Million), 2021–2032

Figure 38. Southeast Asia Tuberculosis Diagnostics Testing Market Size YoY Growth (US$ Million), 2021–2032

Figure 39. India Tuberculosis Diagnostics Testing Market Size YoY Growth (US$ Million), 2021–2032

Figure 40. Australia & New Zealand Tuberculosis Diagnostics Testing Market Size YoY Growth (US$ Million), 2021–2032

Figure 41. Latin America Tuberculosis Diagnostics Testing Market Size YoY Growth (US$ Million), 2021–2032

Figure 42. Latin America Tuberculosis Diagnostics Testing Market Share by Country (2021–2032)

Figure 43. Mexico Tuberculosis Diagnostics Testing Market Size YoY Growth (US$ Million), 2021–2032

Figure 44. Brazil Tuberculosis Diagnostics Testing Market Size YoY Growth (US$ Million), 2021–2032

Figure 45. Middle East & Africa Tuberculosis Diagnostics Testing Market Size YoY Growth (US$ Million), 2021–2032

Figure 46. Middle East & Africa Tuberculosis Diagnostics Testing Market Share by Country (2021–2032)

Figure 47. Israel Tuberculosis Diagnostics Testing Market Size YoY Growth (US$ Million), 2021–2032

Figure 48. Saudi Arabia Tuberculosis Diagnostics Testing Market Size YoY Growth (US$ Million), 2021–2032

Figure 49. UAE Tuberculosis Diagnostics Testing Market Size YoY Growth (US$ Million), 2021–2032

Figure 50. Abbott Laboratories Revenue Growth Rate in Tuberculosis Diagnostics Testing Business (2021–2026)

Figure 51. Becton, Dickinson and Company (BD) Revenue Growth Rate in Tuberculosis Diagnostics Testing Business (2021–2026)

Figure 52. BioMerieux SA Revenue Growth Rate in Tuberculosis Diagnostics Testing Business (2021–2026)

Figure 53. Cepheid (Danaher Corporation) Revenue Growth Rate in Tuberculosis Diagnostics Testing Business (2021–2026)

Figure 54. Hologic, Inc. Revenue Growth Rate in Tuberculosis Diagnostics Testing Business (2021–2026)

Figure 55. Hain Lifescience GmbH Revenue Growth Rate in Tuberculosis Diagnostics Testing Business (2021–2026)

Figure 56. Oxford Immunotec (PerkinElmer) Revenue Growth Rate in Tuberculosis Diagnostics Testing Business (2021–2026)

Figure 57. Qiagen N.V. Revenue Growth Rate in Tuberculosis Diagnostics Testing Business (2021–2026)

Figure 58. Roche Molecular Systems Inc. Revenue Growth Rate in Tuberculosis Diagnostics Testing Business (2021–2026)

Figure 59. Siemens Healthineers AG Revenue Growth Rate in Tuberculosis Diagnostics Testing Business (2021–2026)

Figure 60. Thermo Fisher Scientific Inc. Revenue Growth Rate in Tuberculosis Diagnostics Testing Business (2021–2026)

Figure 61. Bottom-up and Top-down Approaches for This Report

Figure 62. Data Triangulation

Figure 63. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions